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ABSTRACT
Hip fracture risk is known to be related to material properties of the proximal femur, but fracture prediction studies adding richer
quantitative computed tomography (QCT) measures to dual-energy X-ray (DXA)-based methods have shown limited improvement.
Fracture types have distinct relationships to predictors, but few studies have subdivided fracture into types, because this necessitates
regionalmeasurements andmore fracture cases. Thisworkmakesuse of cortical bonemapping (CBM) to accurately assess, withnoprior
anatomical presumptions, the distribution of properties related to fracture type. CBM uses QCT data to measure the cortical and
trabecular properties, accurate even for thin cortices below the imaging resolution. TheOsteoporotic Fractures inMen (MrOS) study is a
predictive case-cohort studyofmenover 65 years old: we analyze 99 fracture cases (44 trochanteric and 55 femoral neck) compared to a
cohort of 308, randomly selected from 5994. To our knowledge, this is the largest QCT-based predictive hip fracture study to date, and
theﬁrst to incorporateCBManalysis into fractureprediction.Weshowthatbothcorticalmass surfacedensityandendocortical trabecular
BMD are signiﬁcantly different in fracture cases versus cohort, in regions appropriate to fracture type.We incorporate these regions into
predictivemodels usingCoxproportionalhazards regression toestimatehazard ratios, and logistic regression to estimateareaunder the
receiveroperatingcharacteristic curve (AUC). AddingCBMtoDXA-basedBMD leads toa small but signiﬁcant (p< 0.005) improvement in
model prediction for any fracture, with AUC increasing from 0.78 to 0.79, assessed using leave-one-out cross-validation. For speciﬁc
fracture types, the improvement ismore signiﬁcant (p< 0.0001),withAUC increasing from0.71 to 0.77 for trochanteric fractures and0.76
to0.82 for femoral neck fractures. In contrast, addingDXA-basedBMDto aCBM-basedpredictivemodel doesnot result in any signiﬁcant
improvement. © 2015 The Authors. Journal of Bone and Mineral Research published byWiley Periodicals, Inc. on behalf of the American
Society for Bone and Mineral Research. This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
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Introduction
Hip fractures are the most common cause of acuteorthopedic hospital admission in older people.(1) Bone
mineral density (BMD) is an important imaging marker that
contributes to an individual’s fracture risk, and is usually
measured as areal BMD from dual-energy X-ray (DXA), though
volumetric BMD fromquantitative computed tomography (QCT)
is a viable surrogate. Although BMD is speciﬁc(2,3) it lacks
sensitivity,(3–5) missing the majority who go on to fracture. There
is now growing evidence that focal, structural weaknesses may
predispose a hip to fracture.(6–8) The distribution of both
trabecular and cortical bone is critical in determining a femur’s
resistance to fracture.(9–12) Drug treatment and exercise regimes
targeted at reducing fracture risk result in changes that are
focused in particular regions rather than dispersed over the
whole bone.(13,14)
Cortical bone mapping (CBM) is a technique that allows
measurement of cortical variables from clinical QCT data; CBM
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has been presented and thoroughly validated in previous
works.(15–17) Using CBM, it is possible to accurately measure
cortical thickness (CTh, mm), cortical mass surface density (CM,
mg/cm2, the cortical mass per unit cortical surface area), cortical
bone mineral density (CBMD, mg/cm3), and endocortical
trabecular bone mineral density (ECTD, mg/cm3, the average
density in the trabecular compartment close to the cortex). This
is distinct from alternative measures in two important ways.
First, it provides a genuinely local measurement of cortical
properties: these are independently measured at many
thousand locations distributed over the surface of the proximal
femur. Particular cortical regions that may be related to
particular types of fracture are found from a statistical analysis
of these measurements, rather than pre-grouping them into
anatomical regions and testing each region in turn for
signiﬁcance. Such an analysis has been applied to hip fracture
before,(18) but using voxel-based BMD rather than surface-based
cortical measurements. Second, measurements are accurate
even when the cortex is much thinner than the extent of the CT
imaging blur. In contrast, in most alternative techniques, for thin
cortices (<3mm) the measured “thickness” when based on
thresholds (either locally variable or ﬁxed), whether or not
reﬁned by morphological operators, is often closer to the width
of the CT imaging blur, and the measured “density” (ie, the
recorded cortical CT value) is in fact closer to cortical mass
surface density, rather than true cortical BMD.
Here we apply CBM for fracture prediction, in a study of male
subjects, some of whom have gone on to fracture their femur.
QCT data from this study has been analyzed before using both
DXA-derived and QCT-derived regional bone quantities,(19)
though with a different randomly selected cohort. This present
work is the ﬁrst application of CBM to a predictive fracture-risk
study. It also reports on a much larger number of cases than
previously published results: 99 rather than the previously
reported 40. As a result, we consider these cases in two separate
fracture groups (trochanteric and neck fractures) for the ﬁrst
time in a male cohort, although there have been previous
discriminatory analyses of fracture type in female co-
horts.(11,18,20) Using CBM we can show the different patterns
of relationship between fracture type and cortical distributions
and hence start to consider the assessment of not only whether
a particular hip is at risk of fracture, but where that fracture is
most likely to occur. This is of particular importance when
considering that both exercise and drug regimes improve bone
in speciﬁc areas: the eventual goal is to be able to match a
particular individual at risk of fracture to the regime which will
best ameliorate their speciﬁc fracture risks.
Subjects and Methods
Study design
The Osteoporotic Fractures in Men (MrOS) study(21,22) recruited
5994 men in the United States fromMarch 2000 until April 2002.
Eligible subjects from six clinical sites were 65 years or older, able
to walk without assistance, and had not had bilateral hip
replacement surgery. Various measurements at baseline includ-
ed areal BMD at the hip by DXA (QDR 4500W; Hologic Inc.,
Bedford, MA, USA) and subject weight and height. Information
about fractures was ascertained through questionnaires re-
turned by the subjects every 4 months; however, any reported
hip fractures were validated by centralized physician review of
the radiology report or radiographs. Fracture type was classiﬁed
as “femoral neck,” “subtrochanteric,” “intertrochanteric,” or
“other.”
A subset of 3684 participants (61% of the MrOS cohort) also
had QCT of the hip at baseline. This subset consisted of
approximately the ﬁrst 650 subjects at each of the six centers, in
addition to all those fromminority backgrounds. QCT scanswere
performed on a variety of machines, but according to a protocol
delivering 512 512 pixel slices at 3mm separation, covering
the femoral head to 3.5 cm below the lesser trochanter. All scans
included a calibration phantom (calcium hydroxyapatite at 150,
75, and 0mg/cm3; Image Analysis Inc., Columbia, KY, USA) for
converting fromHounsﬁeld Units (HU) to BMD. A total of 3572 of
these scans were successfully transferred to the study center for
processing, and QCT-derived volumetric BMD values were
calculated from a further subset of 3358. Scanning and selection
procedures, baseline statistics compared to the entire cohort,
and details of the QCT-derived measurements have been
described fully elsewhere.(23)
The analysis of this study follows a case-cohort design.(24) The
MrOS study team took the 3572 participants with hip QCT scans
and removed any with previous hip fracture or hip replacement,
leaving 3515. The cases were all 104 participants from this set
with hip fractures as of February 2012. Three times this number
(312) were taken as a random sample from the whole set to form
the cohort, of which 10 had fractured and hence were also in the
cases, leaving a total sample size of 406. Eight participants were
excluded from the analysis because of problems with the QCT
data (two incomplete scans, four severely misregistered scans,
one incomplete phantom scan, and one extremely noisy
reconstruction), leaving 398 in the ﬁnal analysis. Of these 398,
308were in the cohort and 99were fracture cases. Fracture types
were loosely grouped into two categories, giving 44 “trochan-
teric” (37 intertrochanteric, 4 subtrochanteric, and 3 other) and
55 “neck” fractures.
An additional set of 38 QCT scans was also supplied, for
analyzing CBM reproducibility. This consisted of two indepen-
dent scans at visits 3 months apart from each of 19 men.
CBM
The ﬁrst step in CBM is an approximate segmentation of each
proximal femur from the QCT data for each subject. This
segmentation is performed using in-house–developed software
Stradwin (free to download from http://mi.eng.cam.ac.uk/~rwp/
stradwin), and results in a triangulated surface mesh with
between 5,000 and 15,000 vertices distributed uniformly over the
proximal femoral surface. This is the only manual step in the CBM
process. These vertices are used to establish the location and
directions at which more accurate, fully automated, measure-
ments of cortical variables (including more precise surface
location) are made. Hence the manual segmentation is only
required tobeaccurate towithin 2mmof the real femoral surface.
CBMmeasurements are thenmade at each vertex, again using
in-house Stradwin software. This is followed by non-rigid
registration of each femur from each subject to a canonical
femur surface (derived from an average of many hundred
femurs) and mapping of the CBM data to that surface, using
another in-house package wxRegSurf (free to download from
http://mi.eng.cam.ac.uk/~ahg/wxRegSurf). Statistical paramet-
ricmapping (SPM) is then applied, using the SurfStat(25) package,
to identify patches of differences in any of these variables
associated with each fracture type (trochanteric or neck). Where
both hips were available (in 358 out of 398 subjects) results were
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averaged over the left and right femur; otherwise, data was used
from whichever hip was available. We have previously shown
that (at least in older women), although there are some
differences between left and right femurs from the same subject,
these are relatively small and do not generally appear in areas
associated with fracture.(26)
The general linear model variables used in SPM to discover
patches for each of CTh, CM, CBMD, or ECTD, were group,
fracture, age, weight, clinical site, and shape. Groupwas bimodal
(case or cohort) whereas fracture was trimodal (none, trochan-
teric, neck). Clinical site was used to model any variations in
scanner calibration and regional demographics. Tomodel shape
we used the ﬁve most signiﬁcant shape modes: with size, these
account for 86% of the total shape variance. However, we do not
include size in the model because it is known to correlate with
fracture, and would hence reduce the fracture-sensitive CBM
patches. The ﬁve shape modes are required as confounding
variables to account for any systematic misregistration during
the mapping process.(27) For each cortical variable, we identiﬁed
two patches (ie, the regions where there was signiﬁcant contrast
between the cohort and the speciﬁc fracture type): one patch for
trochanteric fractures, and another for femoral neck fractures.
Having identiﬁed these patches, the cortical data was averaged
within the corresponding patch. This gives single values per
patch, cortical variable, and subject. As a result of a prior
discriminative study on a different data set,(11,28) it was decided
in advance of this study only to use the CM and ECTD patches for
analysis of hazard and odds ratios, giving four variables in all to
carry forward into the next phase of statistical analysis. CTh and
CBMD patches are nevertheless also reported for completeness.
All stages previous to SPM analysis were carried out blinded
to case and fracture status, and all the analysis (with the
exception of some additional predictive models highlighted in
the following section) was according to a study plan that had
been previously submitted to, and approved by, the MrOS study
group. The process is summarized in the top section of Fig. 1.
Predictive models
Variables of interest were age, height, DXA-based areal BMD
(total hip [ThBMD] and femoral neck [FnBMD]), and QCT-based
integral volumetric BMD (total hip and femoral neck), as well as
the CM and ECTD patches based on CBM analysis for trochanteric
and neck fracture. Outcomes were either any fracture, or
trochanteric fracture, or femoral neck fracture. QCT-based BMD
measurements were provided for 384 of the 398 subjects.
Fig. 1. Flowchart describing the process for creating and validating predictive linear models based on CBM variables.
Journal of Bone and Mineral Research PREDICTING HIP FRACTURE TYPE WITH CBM IN THE MROS STUDY 2069
Modeling of the time to ﬁrst incident hip fracture was
performed using Cox proportional hazards regression with the
Barlow weighting method and robust variance estimation,
necessitated by the case-cohort design. Hazard ratios were
estimated for hip fracture for a 1 SD change in each imaging
variable, adjusted for age, height, and clinical site. According to
Barlow’s method for weighting study participants in the pseudo-
likelihood, cases were weighted by 1 and subcohort controls
were weighted by the inverse of the sampling fraction, where
a¼ 308/3515¼ 8.8%. Case-cohort analyses for hazard ratioswere
conducted in SAS version 9.1 (SAS Institute, Inc., Cary, NC, USA).
In addition, we examined the ability of models involving
different groups of variables to predict 10-year fracture incidence,
by performing either binomial (any fracture) or trichotomous
multinomial (speciﬁc fracture type) logistic regression (MNR) for
various models, allowing for age, height, and clinical site. Logistic
models were created using MATLAB R2014a (The MathWorks,
Inc., Natick, MA, USA). We calculated odds ratios for each variable
individually. We investigated predictive models including no
imaging variables, DXA-derived BMD values only, QCT-derived
BMD values only, CBM patches only, DXA and CBM patches, and
QCT and CBM patches. Receiver operating characteristic (ROC)
curves were calculated with leave-one-out cross-validation.
Because the location of the CBM patches were also dependent
on the data, SPM for calculating the patches was also included in
the leave-one-out process. Hence, for each subject, fracture
probability for each type of fracture was predicted from a model
based on the remaining subjects, and also (where contained in
the model) from CBM patches based on the remaining subjects.
This process is summarized in the lower section of Fig. 1.
We used a signiﬁcance level of p< 0.005 for hazard ratios,
odds ratios, and for comparing models, as a conservative
Bonferroni correction given that there are up to 10 variables
under consideration in the main analysis (age, height, and all
DXA, QCT, and CBM values).
The predictivemodels listed in this sectionwere all determined
prior to any data analysis as part of a plan submitted to the MrOS
study group. This is particularly important for model selection,
because overoptimistic results can be generated if selection of
variables is based on model performance. Nevertheless, some
additional models were selected after the analysis, to allow
comparison with previous studies.(19,29) These models included
other DXA-based variables (trochanteric and intertrochanteric
areal BMD, to give four in total) and QCT-based variables (tro-
chanteric, femoral neck, and total hip volumetric BMD in integral,
cortical, and trabecular compartments, to give nine in total).
Precision
Precision of the CBM variables was assessed with an additional
set of QCT data that consisted of 38 scans of 19 subjects, with
two independent scans of each subject. CBM variables were
derived from these scans in the same way as for the other
analyses above andmapped to the canonical femurmodel. Each
scan was processed blinded to subject. The variance of the
measurement error was assumed to be one-half the variance of
the measurement differences from each pair of scans of the
same subject (because if the measurement error is normally
distributedwith zeromean, the difference between two samples
of the same measurement has twice the variance of each of the
samples alone). The measurement SD was calculated for each
CBM variable, at each location on the canonical femur, because
the precision was expected to vary with anatomical location.
We also calculated the SD of the CBM variables after averaging
these over the patches found in the SPM analysis.
Results
Baseline data for no fracture and for the fracture cases is given in
Table 1.
Figure 2 shows the result of running the SPM analysis over all
subjects (actually the patches used in the statistical models are
very slightly different, because each of these leaves one subject
out; however, the effect of this variation is almost invisible in this
ﬁgure). Results are shown for all CBM variables, though only CM
and ECTD were subsequently used in calculating hazard ratios
and in the predictive models. These results are shown as
percentage difference with respect to the mean value at each
point. This is slightly problematic for ECTD, because the average
trabecular bone mineral density can be very near to zero, and
hence a small absolute change may lead to a large percentage
change. Nevertheless, we prefer to visualize percentage
changes, because they are more closely linked to the statistically
signiﬁcant regions: a larger absolute change is generally
required in an area with larger mean value to attain signiﬁcance.
Hazard ratios (from Cox regression) and odds ratios (from
binomial and multinomial logistic regression) are shown in
Tables 2 and 3, respectively. These contain ratios for fractures of
any type, as well as for speciﬁc (trochanteric or neck) fracture
types. Predictive models were assessed using leave-one-out
cross validation, and subsequent ROC curves are shown in Fig. 3.
Areas under these curves (AUCs) were calculated, with
conﬁdence bounds determined by the bootstrap technique,
Table 1. Baseline Values for the Study
No fracture
Fractures
(n¼ 299)a All (n¼ 99)a Trochanteric (n¼ 44)a Neck (n¼ 55)a
Quantity Mean SD Mean SD p Mean SD p Mean SD p
Age (years) 73.4 5.7 76.8 5.8 <0.001 75.5 5.7 0.025 77.8 5.7 <0.001
Weight (kg) 84.6 14.1 80.7 13.0 0.017 78.8 11.4 0.010 82.3 14.1 0.263
Height (cm) 174.4 7.3 174.3 6.3 0.840 174.1 6.0 0.758 174.4 6.5 0.990
DXA ThBMD (g/cm2) 0.956 0.132 0.837 0.131 <0.001 0.827 0.120 <0.001 0.844 0.140 <0.001
DXA FnBMD (g/cm2) 0.786 0.119 0.675 0.105 <0.001 0.679 0.107 <0.001 0.672 0.104 <0.001
QCT ThBMD (g/cm3) 0.278 0.049 0.236 0.049 <0.001 0.233 0.047 <0.001 0.238 0.051 <0.001
QCT FnBMD (g/cm3) 0.286 0.057 0.242 0.053 <0.001 0.244 0.052 <0.001 0.240 0.053 <0.001
Signiﬁcant differences of p are compared to no fracture.
aQCT values were given for a subset of the data, with n¼ 288, 96, 43, and 53, respectively.
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Fig. 2. CBM effects related to each fracture type, shown as percentage differences between fracture cases and cohort. Paler colors indicate no signiﬁcant
relationship between fracture type and the CBM quantity. The left-hand images concern trochanteric fracture, the right-hand images concern neck
fracture. Color scales are the same for A–F; G and H have a slightly expanded scale, with the zero at the same color. Viewpoints are labeled in A and are
consistent throughout.
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and these are contained in Table 4. The models were assessed
for signiﬁcant difference by comparing the deviances of nested
models, using a x2 test. This is a goodness-of-ﬁt test that directly
compares how well the model ﬁts the data: in this case how
closely the fracture probabilities output for each subject from
each model (after cross-validation) match the actual fracture
events. It is only valid for comparing nested models; ie, two
models where one model is a subset of the other.
The precision of CBM variables was also assessed and the
estimated measurement SDs are given in Table 5. This is
reported as an absolute value, percentage of the mean value
(percentage coefﬁcient of variation), and also as a percentage of
the SD of that variable in the full cohort. This latter value gives a
better indication of how useful this measurement is as a
predictor, because it is approximately one-half the minimum
detectable difference for a single subject, at 95% conﬁdence.
The distribution of measurement error is also given in Fig. 4.
Discussion
Looking at the baseline ﬁgures in Table 1, the results for DXA-
and QCT-based BMD largely conﬁrm what has already been
widely reported: that all of these measures are clearly predictive
of fracture, though it is interesting to note that this is the case for
either class of fractures, irrespective of whether BMD is
measured over total hip or femoral neck. Weight, height, and
age results agree well with a previous discriminative study on
women,(20) conﬁrming that age is a stronger predictor, as well as
discriminator, of fracture than either weight or height. However,
age shows much more signiﬁcance for neck fracture than for
trochanteric fracture, whichmay well be related to the particular
regions associated with age-related bone loss(23) and how these
compare to those regions associated with each fracture type in
Fig. 2. In contrast, reduced weight shows signiﬁcance for
trochanteric but not neck fractures, though at a fairly low
signiﬁcance level.
CBM
The ﬁrst step in assessing how CBMmight contribute to fracture
risk is to detect over which parts of the proximal femur each CBM
variable is associated with fracture; this is shown in Fig. 2, for
CTh, CM, CBMD, and ECTD. The distribution and percentage
changes in cortical thickness and cortical mass surface density
show a striking similarity to those found by the same method in
a published independent discriminative study inwomen.(11,28) In
both cases, particularly with CM, there is a clear patch at the
superolateral side of the trochanter associated with trochanteric
fracture, and an even clearer patch at the superior femoral neck
Table 2. Hazard Ratios for Each 5-Year Increase (Age), 1 SD Increase (Height), or 1 SD Decrease (All Others) in Quantity
All fractures Trochanteric fracture Neck fracture
Quantity Hazard ratio 95% CI Hazard ratio 95% CI Hazard ratio 95% CI
Age 1.81a 1.47–2.23 1.52a 1.15–2.02 2.10a 1.62–2.73
Height 0.97 0.79–1.19 0.94 0.71–1.23 0.99 0.76–1.28
DXA ThBMD 2.86a 1.98–4.12 3.52a 2.24–5.54 2.56a 1.63–4.01
DXA FnBMD 3.65a 2.30–5.78 3.86a 2.07–7.22 3.70a 2.05–6.69
QCT ThBMD 3.28a 2.11–5.11 3.94a 2.22–7.01 2.94a 1.70–5.09
QCT FnBMD 2.80a 1.83–4.28 2.88a 1.71–4.82 2.82a 1.63–4.88
CM trochanter patch 2.34a 1.67–3.28 3.45a 2.13–5.58 1.80a 1.24–2.62
CM neck patch 3.00a 2.06–4.38 2.80a 1.80–4.35 3.32a 1.98–5.58
ECTD trochanter patch 3.70a 2.39–5.72 4.63a 2.59–8.30 3.25a 1.86–5.66
ECTD neck patch 4.87a 2.91–8.14 4.52a 2.51–8.13 5.36a 2.57–11.18
Hazard ratios calculated from an unadjusted model (for age and height) or age þ height þ site þ quantity (for all others).
aSigniﬁcance is given for p< 0.005.
Table 3. Odds Ratios for 10-Year Fracture Incidence for Each 5-Year Increase (Age), 1 SD Increase (Height), or 1 SD Decrease (All Others)
in the Quantity
All fractures Trochanteric fracture Neck fracture
Quantity Odds ratio 95% CI Odds ratio 95% CI Odds ratio 95% CI
Age 1.75a 1.40–2.18 1.41 1.05–1.89 2.11a 1.58–2.81
Height 1.06 0.83–1.37 1.00 0.71–1.40 1.12 0.82–1.54
DXA ThBMD 2.58a 1.91–3.50 2.96a 1.98–4.43 2.32a 1.62–3.32
DXA FnBMD 3.08a 2.19–4.34 3.11a 1.99–4.85 3.07a 2.02–4.67
QCT ThBMD 2.68a 1.94–3.71 3.21a 2.07–4.97 2.33a 1.59–3.42
QCT FnBMD 2.33a 1.69–3.20 2.46a 1.61–3.74 2.21a 1.50–3.27
CM trochanter patch 2.28a 1.70–3.06 3.31a 2.15–5.09 1.78a 1.27–2.50
CM neck patch 2.52a 1.86–3.41 2.40a 1.63–3.55 2.61a 1.79–3.82
ECTD trochanter patch 3.01a 2.17–4.17 3.49a 2.23–5.45 2.69a 1.83–3.96
ECTD neck patch 3.33a 2.35–4.72 3.08a 1.98–4.80 3.57a 2.31–5.50
Odds ratios calculated from a model of age þ height þ site (for age and height) or age þ height þ site þ quantity (for all others).
aSigniﬁcance is given for p< 0.005.
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associated with neck fracture. This might not be a surprising
result in general; in fact it would be worrying if CBM variables
were not located in regions associated with that fracture type,
but nevertheless it is striking that the shape and location of
these patches is so consistent between studies. The CBM
patches are also fairly consistent with a previous study using a
voxel-based analysis on a smaller female cohort.(18) Most of the
cases in that study (29/38) sustained neck fractures, and the
detected voxel-based regions associatedwith fracture are hence
most similar to the ECTD neck patches in Fig. 2.
Fig. 3. ROC curves for fracture prediction based on leave-one-out cross-validation of MNRmodels. The basemodel m includes ageþheightþ site. (A, C,
E) The left-hand graphs show results for either of DXA, QCT, or CBM variables added to this base model. (B, D, F) The right-hand graphs show results for
adding CBM variables to models already containing either DXA or QCT variables. The top row shows trochanteric fracture prediction (A, B), the middle
row neck fracture prediction (C, D), and the bottom row prediction of any type of fracture (E, F). Numerical results for these models are given in Table 4.
MNR¼multinomial logistic regression.
Journal of Bone and Mineral Research PREDICTING HIP FRACTURE TYPE WITH CBM IN THE MROS STUDY 2073
Looking at CBMD distribution in Fig. 2E and F, this does
appear to be associated with trochanteric fracture, and in
regions which are appropriate to that fracture type; however,
the percentage difference is much smaller between cases and
cohort. When this is considered in light of the substantially
poorer precision of this measurement as seen in Table 5 and
Fig. 4, then it would seem unlikely that this will perform well as
a predictor, even if there are some detectable differences in
fracture cases. In addition, the relatively low variation of CBMD
between cases and cohort underlies the similarity between the
CTh and CM distributions. Hence our prior decision to include
neither CTh nor CBMD in the predictive models seems
justiﬁed: in the former case there is similar information and
at slightly better precision in CM, and in the latter case the
Table 4. Cross-Validated AUCs for Various Predictive Models
Binomial Multinomial
All fractures Trochanteric fracture Neck fracture
Model AUC 95% CI DEV AUC 95% CI AUC 95% CI DEV
m 0.653 0.59–0.71 425 0.482 0.40–0.57 0.695 0.62–0.76 562
mþDXA 0.783 0.72–0.83 369a 0.714 0.63–0.78 0.762 0.69–0.83 508a
mþQCT 0.763 0.70–0.82 365a 0.731 0.64–0.80 0.732 0.65–0.80 498a
mþCBM 0.787 0.73–0.84 361a 0.777 0.68–0.84 0.818 0.75–0.87 466a
mþDXAþCBM 0.790 0.73–0.84 362 0.767 0.68–0.84 0.817 0.75–0.87 471c
mþQCTþCBM 0.794 0.74–0.85 343b,c 0.765 0.67–0.83 0.834 0.77–0.89 446b,c
mþ all DXA 0.782 0.73–0.83 372a 0.699 0.61–0.78 0.777 0.69–0.84 508a
mþ all QCT 0.756 0.69–0.81 370a 0.704 0.62–0.79 0.719 0.63–0.79 513a
Combined model 1 0.779 0.72–0.84 359a 0.689 0.60–0.76 0.760 0.69–0.82 497a
Combined model 2 0.783 0.72–0.83 355a 0.700 0.62–0.77 0.757 0.68–0.82 498a
AUCs calculated using binomial (all fractures) or multinomial (speciﬁc fractures) logistic regression. The base model m includes ageþheightþ site.
Signiﬁcance (based on DEV) is given for p< 0.005, based on themodel compared to am, bmþCBM, or cthe samemodel without CBM variables. The last 4
models were selected postanalysis: “all DXA” includes all 4 listed DXA variables; “all QCT” includes all 9 listed QCT variables; “Combined model 1”(28) is
mþDXA FnBMDþQCT trabecular FnBMD; and “Combined model 2”(18) is mþDXA FnBMD and ThBMDþ all 3 QCT trabecular BMD values.
AUC¼ area under the receiver-operating characteristic curve; DEV¼deviance.
Fig. 4. Precision of local CBMmeasurements. The images show how the absolute measurement error (SD) of each CBM variable varies over the femoral
surface: CTh (A); CM (B); CBMD (C); and ECTD (D). Viewpoints are the same as described in Fig. 2A.
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CBMD changes are much too small compared to the
measurement precision.
The ECTD distribution in Fig. 2G and H, on the other hand,
shows quite dramatic differences between fracture cases and
cohort, and between the fracture types. Although this difference
is signiﬁcant over much of the proximal femur, the distributions
are quite distinct between trochanteric and neck fractures. As
with CM, CBM patches for trochanteric fracture are focused on
the superolateral trochanter, and neck fractures at the superior
femoral neck, with substantially less involvement on the
inferomedial side. This is a particularly interesting result, given
that it is known that the inferomedial femoral neck is largely
preserved with age,(6) and may go some way to explaining why
this preservative effect does not prevent neck fracture risk
increasingwith age. It should be noted here that, although ECTD
is clearly very signiﬁcant, the percentages in Fig. 2G andH (which
have an increased scale compared to the other subﬁgures) need
to be interpreted with care given that the mean ECTD can
approach a value close to zero.
We have already discussed the relatively poor performance
of the CBMD measurement compared to the other CBM
variables. Looking at the other precision values in Table 5
clariﬁes that this is largely due to the small variation of this
variable in the cohort: all point-wise errors are at around 5% of
the mean value, but CBMD has a much smaller cohort
variation. The distribution of these errors in Fig 4 reveals that
there is a repeatable pattern to where they tend to occur. For
CTh and CM, there are larger errors around the femoral head
and also at the medial side of the lesser trochanter. The former
is due to the presence of the acetabulum, which is very close to
the femur at this point and makes it harder to separate out the
respective cortices in this region. In the latter area, the cortex is
often not well modeled as a single layer and the measure-
ments are less precise as a result. Fortunately, most of the
patches in Fig. 2A–D are not coincident with these high-error
regions, and hence the CBM precision after aggregation over
these patches is substantially better, at about 1% of the mean.
ECTD is not affected by the acetabulum but suffers similar
imprecision at the medial side of the lower trochanter.
Fracture prediction
As expected, hazard ratios in Table 2 are signiﬁcant for all BMD
measures, with QCT-based ThBMD the most signiﬁcant for
trochanteric fracture (and for any fracture), but DXA-based
FnBMD is the quantity of choice for neck fracture. In contrast to
QCT, the DXA-derived areal BMDs contain some measure of
size as well as volumetric density, and this may contribute to the
improved performance for neck fracture from what is otherwise a
less direct measurement of BMD. Nevertheless, hazard ratios
between DXA and QCT BMD are largely similar, supporting the
general results from previous studies that fail to show any
signiﬁcantbeneﬁt fromadding suchQCTmeasurement to fracture
predictors which already include DXA measurements.(19,20,29)
Hazard ratios for CM are similar to those for BMD; however,
ECTD hazard ratios are somewhat larger, a similar result to that
found by Yang and colleagues,(19) where their trabecular
volumetric BMD measurements also tended to be the best
predictors. This is not a surprising result, because their work was
based on data from the same study, but it conﬁrms that the
result holds true for our larger sample size, and indicates that our
measurement of endocortical trabecular density is capturing the
important information contained within the trabecular com-
partment. All CBM patches show greater hazard ratios for the
fracture type on which they were based.
The odds ratios for 10-year fracture incidence in Table 3 are
somewhat smaller than the hazard ratios, because the predictive
model to which these lead is designed only to detect whether a
subject will fracture, not how long it will be before they fracture.
Hence there is some loss of information: it may be presumed
that those who fracture a long time after the initial baseline scan
had relatively thicker or stronger bones at baseline than those
who fractured soon afterward. The predictive model does not
take advantage of this information, but nevertheless is necessary
in order to evaluate how well we can predict fracture outcome.
Although the results here for DXA and QCT BMD are again quite
similar, it is the DXA-derived FnBMD that has the higher odds
ratio for all fractures, as well as for neck fractures: QCT-based
ThBMD is still higher for trochanteric fracture. However, as with
hazard ratios, ECTD ratios are the most signiﬁcant.
Of more importance is how well these quantities perform
when combined into predictive models. The ROC curves for just
age and height in the left hand graphs of Fig. 3 show that any
useful fracture prediction that these might give is purely due to
neck fractures: these variables have little power to predict
trochanteric fracture. Adding DXA-based BMD greatly improves
performance, although it is clear that ability to predict
trochanteric fracture is still much more limited than for neck
fracture, a similar result to a recent study on the use of ﬁnite
element analysis in fracture prediction.(30) AUCs for these
models in Table 4 are somewhat smaller than have occasionally
been recorded in the literature. Similar models, including DXA
variables, have reported AUCs for any fracture type of 0.86(19)
and 0.80,(20) rather than our value of 0.78. The former was based
Table 5. Estimated Precision (SD) of Measurement Repeatability
Precision
Quantity Absolute
% of Mean (%
coefficient of
variation)
% of SD
in cohort
CTh (mm) 0.099 6.22 9.8
CTh trochanter
patch (mm)
0.033 1.06 2.97
CTh neck patch
(mm)
0.027 1.07 2.41
CM (mg/cm2) 9.14 5.20 7.27
CM trochanter
patch (mg/cm2)
3.98 1.32 2.46
CM neck patch
(mg/cm2)
3.08 1.15 2.20
CBMD (mg/cm3) 34.7 3.17 42.3
CBMD trochanter
patch (mg/cm3)
17.5 1.63 26.6
CBMD neck patch
(mg/cm3)
19.3 1.76 26.5
ECTD (mg/cm3) 15.0 8.81 21.2
ECTD trochanter
patch (mg/cm3)
2.47 1.49 3.72
ECTD neck patch
(mg/cm3)
2.63 1.55 4.20
CBMprecision is shownboth for an individualmeasurement, and for all
measurements aggregated within each of the trochanteric and neck
patches. The right-hand column shows the precision as a percentage of
the SD seen in the entire cohort.
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on the same study as this current work, though with a different
cohort and a smaller number of cases. Hence we conclude that
our lower result is probably due to the increased number of
cases in this study, or the different use of cross-validation
techniques. Neither of these previous publications specify how
the AUC results were validated, and it is worth noting that, had
we not used leave-one-out cross-validation in this present work,
all of our AUC results would have increased by up to 0.03,
bringing them more in line with previous results.
In an attempt to compare model performance with other
studies, we have also included four further models, with more
DXA and QCT variables, and also with combinations that are
more similar to good models from previous works. It might
be expected that increasing the granularity of these variables
would improve the differentiation of fracture type, but from
Table 4 this does not seem to be the case: the models with all
parameters do not perform any better. The combined models 1
and 2, similar to those from previous works,(19,29) do seem to
perform better than the individual DXA or QCT models on
predicting any fracture (though a direct test is not possible since
these models are not nested), but they offer no improvement in
differentiating between fractures.
Looking at Fig. 3, it can be seen that any of the models which
are based on CBM results are more capable of distinguishing
between fracture types, with signiﬁcantly increased AUCs for
both neck and trochanteric fracture. It is clear that CBM improves
the ability to distinguish fractures in prediction, and this
improvement remains signiﬁcant when adding CBM quantities
to models which already have either DXA-based or QCT-based
BMD values in them. In contrast, adding DXA to a CBM-based
model does not result in a signiﬁcant improvement, though the
combination with CBM and QCT-based BMD does increase
overall fracture prediction slightly.
DXA is currently the reference imaging modality for fracture
risk assessment, and it is unlikely that its use will change for the
sake of a small improvement in overall fracture risk. However, if a
CT scan is available it could easily be reanalyzed for a CBM-based
fracture prediction, and such concurrent screening is already
under investigation in some areas.(31) Of more immediate
importance, though, are the CBM patches that arise out of this
analysis. These provide a clear treatment target for regimes
aiming to reduce risk of fracture. Both exercise and drug regimes
improve bone in speciﬁc areas, and these are the areas that
appear to be most important.
This study has a number of limitations, many of them
common to other analyses of the MrOS data and considered in
more detail elsewhere.(21,29) Of particular note in this respect is
the inclusion of multicenter QCT data, which resulted in the
necessity to model site as a variable: the likelihood is that some
inconsistencies were due to differences in CT machines which
were not entirely eliminated by calibration. The study was
performed in men, most of whom were white, and hence the
conclusions are fully supported only for this demographic. In
addition, ideally it would have been better to predetermine the
CBM patch location from an independent data set rather than
from the MrOS data, although including the patch deﬁnition
within the cross-validation process went some way to address-
ing this issue. It has already been noted that the CBMpatches are
quite similar to those we had already identiﬁed in another study
involving women:(11,28) this at least hints both that the shape of
the patches might not be dramatically different for other
demographics, and that the conclusions may hence also be
similar in these other scenarios.
In conclusion, CBM results in a small but statistically signiﬁcant
improvement in fracture prediction, even when added to
existing DXA-based or QCT-based BMD. However, it is
considerably better at predicting risk for each type of fracture,
as well as providing a clear treatment target for reducing this
risk.
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